SynthesisClinical drug investigation2023

Glucagon-Like Peptide-1 Receptor Agonist and Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.

Xiaojuan Jiao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.